Research ExplorerPublicationsEstimating the economic consequences of substance use and su...

Estimating the economic consequences of substance use and substance use disorders

Standard

Estimating the economic consequences of substance use and substance use disorders. / Manthey, Jakob; Hassan, Syed Ahmed; Carr, Sinclair; Kilian, Carolin; Kuitunen-Paul, Sören; Rehm, Jürgen.

In: EXPERT REV PHARM OUT, Vol. 21, No. 5, 10.2021, p. 869-876.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Manthey, J, Hassan, SA, Carr, S, Kilian, C, Kuitunen-Paul, S & Rehm, J 2021, 'Estimating the economic consequences of substance use and substance use disorders', EXPERT REV PHARM OUT, vol. 21, no. 5, pp. 869-876. https://doi.org/10.1080/14737167.2021.1916470

APA

Manthey, J., Hassan, S. A., Carr, S., Kilian, C., Kuitunen-Paul, S., & Rehm, J. (2021). Estimating the economic consequences of substance use and substance use disorders. EXPERT REV PHARM OUT, 21(5), 869-876. https://doi.org/10.1080/14737167.2021.1916470

Vancouver

Manthey J, Hassan SA, Carr S, Kilian C, Kuitunen-Paul S, Rehm J. Estimating the economic consequences of substance use and substance use disorders. EXPERT REV PHARM OUT. 2021 Oct;21(5):869-876. https://doi.org/10.1080/14737167.2021.1916470

Bibtex

@article{af6d4ccd9c574df584e2685575d595df,
title = "Estimating the economic consequences of substance use and substance use disorders",
abstract = "INTRODUCTION: This contribution gives an overview on estimating the economic impact of substance use (SU) and substance use disorders (SUDs) from a societal perspective.AREAS COVERED: In this Expert Review, we first discuss the scope of the economic costs of SU to society and the methods used to estimate them. In general, cost studies should not be limited to SUDs, but should also include costs related to the consequences of any type of SU to achieve a comprehensive picture of the societal burden. Further, estimating potentially avoidable costs will increase the value of cost studies. Importantly, methodologically sound cost studies shed light on the magnitude of societal problems related to SU and can be used as a reference point to evaluate regulatory policies and other preventive measures. The area of estimating potential economic benefits of SU is understudied and lacks a theoretical and methodological framework.EXPERT OPINION: Overall, economic studies on the impact of SU and SUDs can strongly contribute to better-informed decision-making in the creation of regulatory and control policies. The least developed area of research refers to a consensus methodology that could be used in studies which compare economic costs to potential economic benefits.",
keywords = "Cost of Illness, Health Care Costs, Health Policy, Humans, Substance-Related Disorders/economics",
author = "Jakob Manthey and Hassan, {Syed Ahmed} and Sinclair Carr and Carolin Kilian and S{\"o}ren Kuitunen-Paul and J{\"u}rgen Rehm",
year = "2021",
month = oct,
doi = "10.1080/14737167.2021.1916470",
language = "English",
volume = "21",
pages = "869--876",
journal = "EXPERT REV PHARM OUT",
issn = "1473-7167",
publisher = "EXPERT REVIEWS",
number = "5",

}

RIS

TY - JOUR

T1 - Estimating the economic consequences of substance use and substance use disorders

AU - Manthey, Jakob

AU - Hassan, Syed Ahmed

AU - Carr, Sinclair

AU - Kilian, Carolin

AU - Kuitunen-Paul, Sören

AU - Rehm, Jürgen

PY - 2021/10

Y1 - 2021/10

N2 - INTRODUCTION: This contribution gives an overview on estimating the economic impact of substance use (SU) and substance use disorders (SUDs) from a societal perspective.AREAS COVERED: In this Expert Review, we first discuss the scope of the economic costs of SU to society and the methods used to estimate them. In general, cost studies should not be limited to SUDs, but should also include costs related to the consequences of any type of SU to achieve a comprehensive picture of the societal burden. Further, estimating potentially avoidable costs will increase the value of cost studies. Importantly, methodologically sound cost studies shed light on the magnitude of societal problems related to SU and can be used as a reference point to evaluate regulatory policies and other preventive measures. The area of estimating potential economic benefits of SU is understudied and lacks a theoretical and methodological framework.EXPERT OPINION: Overall, economic studies on the impact of SU and SUDs can strongly contribute to better-informed decision-making in the creation of regulatory and control policies. The least developed area of research refers to a consensus methodology that could be used in studies which compare economic costs to potential economic benefits.

AB - INTRODUCTION: This contribution gives an overview on estimating the economic impact of substance use (SU) and substance use disorders (SUDs) from a societal perspective.AREAS COVERED: In this Expert Review, we first discuss the scope of the economic costs of SU to society and the methods used to estimate them. In general, cost studies should not be limited to SUDs, but should also include costs related to the consequences of any type of SU to achieve a comprehensive picture of the societal burden. Further, estimating potentially avoidable costs will increase the value of cost studies. Importantly, methodologically sound cost studies shed light on the magnitude of societal problems related to SU and can be used as a reference point to evaluate regulatory policies and other preventive measures. The area of estimating potential economic benefits of SU is understudied and lacks a theoretical and methodological framework.EXPERT OPINION: Overall, economic studies on the impact of SU and SUDs can strongly contribute to better-informed decision-making in the creation of regulatory and control policies. The least developed area of research refers to a consensus methodology that could be used in studies which compare economic costs to potential economic benefits.

KW - Cost of Illness

KW - Health Care Costs

KW - Health Policy

KW - Humans

KW - Substance-Related Disorders/economics

U2 - 10.1080/14737167.2021.1916470

DO - 10.1080/14737167.2021.1916470

M3 - SCORING: Review article

C2 - 33899647

VL - 21

SP - 869

EP - 876

JO - EXPERT REV PHARM OUT

JF - EXPERT REV PHARM OUT

SN - 1473-7167

IS - 5

ER -